Target type: biologicalprocess
Any process that increases the concentration of calcium ions in the endoplasmic reticulum. [GOC:mah]
Positive regulation of endoplasmic reticulum calcium ion concentration is a crucial cellular process that ensures proper function of the endoplasmic reticulum (ER), a critical organelle involved in protein folding, lipid synthesis, and calcium homeostasis. The ER serves as the primary intracellular calcium store, and maintaining a precise balance of calcium levels within its lumen is essential for a wide range of cellular processes.
This process involves the coordinated action of various molecular players that regulate the influx and efflux of calcium ions across the ER membrane. Calcium influx into the ER lumen is primarily mediated by specific calcium pumps, such as the sarco/endoplasmic reticulum calcium ATPase (SERCA) pump. SERCA actively transports calcium ions from the cytosol into the ER lumen against their concentration gradient, utilizing ATP hydrolysis as the energy source.
Calcium efflux from the ER is regulated by a diverse array of calcium channels, including inositol trisphosphate receptors (IP3Rs) and ryanodine receptors (RyRs). IP3Rs are activated by the second messenger inositol trisphosphate (IP3), which is generated in response to various stimuli, including hormones, neurotransmitters, and growth factors. RyRs are activated by calcium itself, leading to calcium-induced calcium release (CICR) from the ER.
Several factors can modulate the activity of these calcium channels and pumps, influencing the overall calcium concentration in the ER. These factors include:
* **Hormonal signaling:** Hormones like insulin and growth hormone can stimulate calcium influx into the ER by activating SERCA pumps.
* **Neurotransmitter release:** Neurotransmitters like glutamate can induce calcium release from the ER via IP3Rs.
* **Stress conditions:** Cellular stress, such as ER stress, can lead to calcium depletion from the ER.
* **Genetic mutations:** Mutations in genes encoding calcium channels or pumps can disrupt calcium homeostasis and contribute to various diseases.
Maintaining a precise balance of calcium concentration in the ER is critical for a variety of cellular processes, including:
* **Protein folding and secretion:** Calcium is essential for the proper folding of proteins within the ER.
* **Lipid biosynthesis:** Calcium plays a role in the synthesis of lipids and cholesterol within the ER.
* **Cellular signaling:** Calcium release from the ER triggers a cascade of signaling events that regulate various cellular functions.
* **Muscle contraction:** In muscle cells, calcium release from the ER initiates muscle contraction.
Dysregulation of ER calcium homeostasis can lead to a variety of cellular dysfunction and disease states, including:
* **ER stress:** Excessive calcium depletion from the ER can trigger a cascade of events known as ER stress, which can lead to apoptosis (programmed cell death).
* **Muscle disorders:** Mutations in genes encoding calcium channels or pumps can cause muscle weakness and other muscle-related disorders.
* **Neurological diseases:** Disruptions in ER calcium homeostasis are implicated in a number of neurological diseases, including Alzheimer's disease and Parkinson's disease.
The intricate interplay of calcium channels, pumps, and regulatory factors ensures the precise control of calcium levels within the ER. Maintaining this delicate balance is critical for cellular function, and disruptions in this process can contribute to a range of diseases.
'"
Protein | Definition | Taxonomy |
---|---|---|
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | A sarcoplasmic/endoplasmic reticulum calcium ATPase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P16615] | Homo sapiens (human) |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | A sarcoplasmic/endoplasmic reticulum calcium ATPase 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O14983] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
2,5-di-tert-butylhydroquinone | 2,5-di-tert-butylbenzene-1,4-diol : A member of the class of hydroquinones that is benzene-1,4-diol substituted by tert-butyl groups at position 2 and 5. | hydroquinones | |
chelerythrine | chelerythrine : A benzophenanthridine alkaloid isolated from the root of Zanthoxylum simulans, Chelidonium majus L., and other Papaveraceae. | benzophenanthridine alkaloid; organic cation | antibacterial agent; antineoplastic agent; EC 2.7.11.13 (protein kinase C) inhibitor |
paxilline | paxilline : An indole diterpene alkaloid with formula C27H33NO4 isolated from Penicillium paxilli. It is a potent inhibitor of large conductance Ca2(+)- and voltage-activated K(+) (BK)-type channels. paxilline: structure given in first source; RN given refers to (2R-(2alpha,4bbeta,6aalpha,12bbeta,12calpha,14abeta))-isomer | diterpene alkaloid; enone; organic heterohexacyclic compound; terpenoid indole alkaloid; tertiary alcohol | anticonvulsant; Aspergillus metabolite; EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor; genotoxin; geroprotector; mycotoxin; Penicillium metabolite; potassium channel blocker |
thapsigargin | thapsigargin : An organic heterotricyclic compound that is a hexa-oxygenated 6,7-guaianolide isolated fron the roots of Thapsia garganica L., Apiaceae. A potent skin irritant, it is used in traditional medicine as a counter-irritant. Thapsigargin inhibits Ca(2+)-transporting ATPase mediated uptake of calcium ions into sarcoplasmic reticulum and is used in experimentation examining the impacts of increasing cytosolic calcium concentrations. Thapsigargin: A sesquiterpene lactone found in roots of THAPSIA. It inhibits SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES. | butyrate ester; organic heterotricyclic compound; sesquiterpene lactone | calcium channel blocker; EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor |
curcumin | curcumin : A beta-diketone that is methane in which two of the hydrogens are substituted by feruloyl groups. A natural dyestuff found in the root of Curcuma longa. Curcumin: A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes. | aromatic ether; beta-diketone; diarylheptanoid; enone; polyphenol | anti-inflammatory agent; antifungal agent; antineoplastic agent; biological pigment; contraceptive drug; dye; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor; EC 1.8.1.9 (thioredoxin reductase) inhibitor; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; flavouring agent; food colouring; geroprotector; hepatoprotective agent; immunomodulator; iron chelator; ligand; lipoxygenase inhibitor; metabolite; neuroprotective agent; nutraceutical; radical scavenger |
biselyngbyaside | biselyngbyaside: antineoplastic from the marine cyanobacterium Lyngbya sp.; structure in first source | ||
alpha-cyclopiazonic acid | alpha-cyclopiazonic acids |